Magda Aguiar

2.3k total citations
24 papers, 429 citations indexed

About

Magda Aguiar is a scholar working on Pathology and Forensic Medicine, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Magda Aguiar has authored 24 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in General Health Professions and 6 papers in Economics and Econometrics. Recurrent topics in Magda Aguiar's work include Vitamin D Research Studies (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Healthcare cost, quality, practices (4 papers). Magda Aguiar is often cited by papers focused on Vitamin D Research Studies (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Healthcare cost, quality, practices (4 papers). Magda Aguiar collaborates with scholars based in Canada, United Kingdom and United States. Magda Aguiar's co-authors include Emma Frew, Susan P. Mollan, Alexandra J. Sinclair, Felicity Evison, Wolfgang Högler, Lazaros Andronis, Miranda Pallan, T H Tulchinsky, Suma Uday and Mark Harrison and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Neurology Neurosurgery & Psychiatry and Epilepsia.

In The Last Decade

Magda Aguiar

21 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magda Aguiar Canada 10 175 133 77 61 60 24 429
Wenli Lu China 9 133 0.8× 162 1.2× 14 0.2× 102 1.7× 54 0.9× 19 480
Richard Menger United States 14 160 0.9× 280 2.1× 22 0.3× 75 1.2× 16 0.3× 75 800
Keith Chambers Canada 10 69 0.4× 32 0.2× 67 0.9× 97 1.6× 62 1.0× 17 545
Rebeca D. Monk United States 9 112 0.6× 49 0.4× 5 0.1× 54 0.9× 18 0.3× 11 615
Peyman Roomizadeh Iran 11 29 0.2× 43 0.3× 54 0.7× 26 0.4× 13 0.2× 21 388
Núria Alcubierre Spain 11 16 0.1× 68 0.5× 128 1.7× 29 0.5× 8 0.1× 13 377
Alexandra Paúl United States 12 288 1.6× 268 2.0× 14 0.2× 70 1.1× 62 1.0× 62 781
Akihiro Toyota Japan 12 108 0.6× 17 0.1× 13 0.2× 48 0.8× 12 0.2× 58 449
Riina Kallikorm Estonia 16 31 0.2× 223 1.7× 3 0.0× 72 1.2× 229 3.8× 37 738
Halina White United States 7 233 1.3× 8 0.1× 9 0.1× 32 0.5× 38 0.6× 15 782

Countries citing papers authored by Magda Aguiar

Since Specialization
Citations

This map shows the geographic impact of Magda Aguiar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Aguiar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Aguiar more than expected).

Fields of papers citing papers by Magda Aguiar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magda Aguiar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Aguiar. The network helps show where Magda Aguiar may publish in the future.

Co-authorship network of co-authors of Magda Aguiar

This figure shows the co-authorship network connecting the top 25 collaborators of Magda Aguiar. A scholar is included among the top collaborators of Magda Aguiar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda Aguiar. Magda Aguiar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walsh, Thomas J., Craig I Coleman, Giulio Alessandri Bonetti, et al.. (2025). Cost-effectiveness of olorofim in the treatment of invasive aspergillosis in patients with limited suitable alternative treatment options: a US payer perspective. Antimicrobial Agents and Chemotherapy. 69(10). e0057025–e0057025.
2.
3.
Trenaman, Logan, Tracey‐Lea Laba, Abdollah Safari, et al.. (2023). The financial burden of accessing care for people with scleroderma in Canada: a patient-oriented, cross-sectional survey. CMAJ Open. 11(4). E630–E636. 1 indexed citations
4.
McDonald, Patrick J., Magda Aguiar, Laura Y. Cabrera, et al.. (2022). Clinician preferences for neurotechnologies in pediatric drug‐resistant epilepsy: A discrete choice experiment. Epilepsia. 63(9). 2338–2349. 8 indexed citations
5.
Aguiar, Magda, Tracey‐Lea Laba, Sarah Munro, et al.. (2021). Co-production of randomized clinical trials with patients: a case study in autologous hematopoietic stem cell transplant for patients with scleroderma. Trials. 22(1). 611–611. 5 indexed citations
6.
Aguiar, Magda, et al.. (2021). Patient perspectives on the British Columbia Biosimilars Initiative: a qualitative descriptive study. Rheumatology International. 42(10). 1831–1842. 9 indexed citations
7.
8.
9.
Frew, Emma, Susan P. Mollan, James Mitchell, et al.. (2021). Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single-payer healthcare system. Surgery for Obesity and Related Diseases. 17(7). 1310–1316. 17 indexed citations
10.
11.
Aguiar, Magda, Mark Harrison, Sarah Munro, et al.. (2020). Designing Discrete Choice Experiments Using a Patient-Oriented Approach. Patient. 14(4). 389–397. 11 indexed citations
12.
Harrison, Mark, Nick Bansback, Magda Aguiar, et al.. (2020). Preferences for treatments to prevent rheumatoid arthritis in Canada and the influence of shared decision-making. Clinical Rheumatology. 39(10). 2931–2941. 15 indexed citations
13.
Aguiar, Magda, Lazaros Andronis, Miranda Pallan, Wolfgang Högler, & Emma Frew. (2019). Micronutrient deficiencies and health-related quality of life: the case of children with vitamin D deficiency. Public Health Nutrition. 23(7). 1165–1172. 7 indexed citations
14.
Aguiar, Magda, Lazaros Andronis, Miranda Pallan, Wolfgang Högler, & Emma Frew. (2019). The economic case for prevention of population vitamin D deficiency: a modelling study using data from England and Wales. European Journal of Clinical Nutrition. 74(5). 825–833. 38 indexed citations
15.
Aguiar, Magda, et al.. (2019). Birth-Related Perineal Trauma in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Maternal and Child Health Journal. 23(8). 1048–1070. 36 indexed citations
16.
Aguiar, Magda & Wolfgang Högler. (2019). Prevention of vitamin D deficiency improves population health, social inequalities and health care budgets. European Journal of Public Health. 30(3). 393–394. 3 indexed citations
17.
Mollan, Susan P., Magda Aguiar, Felicity Evison, Emma Frew, & Alexandra J. Sinclair. (2018). The expanding burden of idiopathic intracranial hypertension. Eye. 33(3). 478–485. 158 indexed citations
18.
Aguiar, Magda, Lazaros Andronis, Miranda Pallan, Wolfgang Högler, & Emma Frew. (2017). Preventing vitamin D deficiency (VDD): a systematic review of economic evaluations. European Journal of Public Health. 27(2). 292–301. 26 indexed citations
19.
Uday, Suma, et al.. (2017). Variations in infant and childhood vitamin D supplementation programmes across Europe and factors influencing adherence. Endocrine Connections. 6(8). 667–675. 56 indexed citations
20.
Högler, Wolfgang, Magda Aguiar, Máiréad Kiely, & Theodore H. Tulchinsky. (2016). Consensus Recommendations for Prevention of Nutritional Rickets: Food Fortification and Micronutrient Supplements for Global Health. AIMS Public Health. 3(1). 40–48. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenli Lu Breakdown of academic impact, for papers by Richard Menger Breakdown of academic impact, for papers by Keith Chambers Breakdown of academic impact, for papers by Rebeca D. Monk Breakdown of academic impact, for papers by Peyman Roomizadeh Breakdown of academic impact, for papers by Núria Alcubierre Breakdown of academic impact, for papers by Alexandra Paúl Breakdown of academic impact, for papers by Akihiro Toyota Breakdown of academic impact, for papers by Riina Kallikorm Breakdown of academic impact, for papers by Halina White
Rankless by CCL
2026